Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
Michael Schulzer45
Canada Sauf Michael Schulzer" 7464
Michael Schulzer Sauf Canada" 1
Canada Et Michael Schulzer 44
Canada Ou Michael Schulzer 7509
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 44.
Ident.Authors (with country if any)Title
000029 Daryl J. Wile [Canada] ; Pankaj A. Agarwal [Inde] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Katherine Dinelle [Canada] ; Elham Shahinfard [Canada] ; Nasim Vafai [Canada] ; Kazuko Hasegawa [Japon] ; Jing Zhang [États-Unis] ; Jessamyn Mckenzie [Canada] ; Nicole Neilson [Canada] ; Audrey Strongosky [États-Unis] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Cyrus P. Zabetian [États-Unis] ; Yu-Shin Ding [États-Unis] ; Mike Adam [Canada] ; Jan Aasly [Norvège] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada]Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
000C55 Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Ramachandiran Nandhagopal [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling
001641 Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto ; Michael Schulzer ; Edwin Mak ; Jacqueline Cragg ; Jess Mckenzie ; Siobhan Mccormick ; Thomas J. Ruth ; Vesna Sossi ; Raul De La Fuente-Fernandez ; A Jon StoesslLongitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
001891 Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
001938 Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jacqueline Cragg [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada]Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
001965 Raúl De La Fuente-Fernandez [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease
001980 Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer ; Edwin Mak ; Vesna SossiTrials of neuroprotective therapies for Parkinson's disease: problems and limitations.
001A52 Sarah C. Lidstone [Canada] ; Michael Schulzer ; Katherine Dinelle ; Edwin Mak ; Vesna Sossi ; Thomas J. Ruth ; Raul De La Fuente-Fernández ; Anthony G. Phillips ; A Jon StoesslEffects of expectation on placebo-induced dopamine release in Parkinson disease.
001B11 Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada]Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
001B78 R. Nandhagopal ; Andre R. Troiano ; Edwin Mak ; Michael Schulzer ; Mary Catherine Bushnell [Canada] ; Alexander Jon Stoessl [Canada]Response to Heat Pain Stimulation in Idiopathic Parkinson's Disease
001C41 André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
001D19 Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada]Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
001D51 Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Siobhan Mccormick ; Michael Schulzer ; Thomas J. Ruth ; A Jon StoesslVisualizing vesicular dopamine dynamics in Parkinson's disease.
001E55 Vesna Sossi [Canada] ; Katherine Dinelle ; Geoffrey J. Topping ; James E. Holden ; Doris Doudet ; Michael Schulzer ; Thomas J. Ruth ; A Jon Stoessl ; Raul De La Fuente-FernandezDopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.
002107 Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada]Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study
002335 W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease
002590 Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study
002816 Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: Positron emission tomographic studies
002843 Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation
002883 Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications
002950 Donald Calne [Canada] ; Michael Schulzer ; Edwin Mak ; A Jon StoesslTreatment for the progression of Parkinson's disease.
002C32 Rau L De La Fuente-Ferna Ndez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model
002D08 Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
002D13 Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada]Placebo mechanisms and reward circuitry: Clues from Parkinson's disease
002D25 Chong S. Lee [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Lisa Kuramoto [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Lack of Regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
002D43 Ajit Kumar [Canada] ; Susan M. Calne [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Zbigniew Wszolek [États-Unis] ; Chris Van Netten [Canada] ; Joseph K. C. Tsui [Canada] ; A. Jon Stoessl [Canada] ; Donald B. Calne [Canada]Clustering of Parkinson disease: Shared cause or coincidence?
002D44 Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; James E. Holden [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [États-Unis] ; Jon Stoessl [Canada]Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms
002D57 Michael Schulzer [Canada] ; Edwin Mak ; Susan M. CalneThe psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease.
002E08 Ajit Kumar ; Sharanpal Mann ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl ; Michael Schulzer ; Chong S. Lee[11C]DTBZ‐PET correlates of levodopa responses in asymmetric Parkinson’s disease
002E91 Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada][11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease
002E92 Susan M. Calne [Canada] ; Edwin Mak [Canada] ; Jeanne Hall [Canada] ; Marie-Jose Fortin [Canada] ; Pamela King [Canada] ; Germaine Mcinnes [Canada] ; Linda Grantier [Canada] ; Sherree Trecartin [Canada] ; Michael Schulzer [Canada]Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's impact scale (PIMS)
003105 Ravikant S. Palur [Canada] ; Caglar Berk ; Michael Schulzer ; Christopher R. HoneyA metaanalysis comparing the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation
003257 Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
003326 Raul De La Fuente-Fernandez [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's disease
003346 Michael Schulzer [Canada]Common pitfalls in the interpretation of statistical tests in the measurement of quality of life in Parkinson's disease
003351 Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover
003485 Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
003507 Chong S. Lee [Canada] ; M. Angela Cenci [Suède] ; Michael Schulzer [Canada] ; Anders Bjo Rklund [Suède]Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease
003729 Claudia Schwab [Canada] ; Michael Schulzer [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada]On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam
003A07 Yue Wang [Canada] ; Grace L. Y. Chan [Canada] ; James E. Holden [États-Unis] ; Teresa Dobko [Canada] ; Edwin Mak [Canada] ; Michael Schulzer [Canada] ; Joseph M. Huser [Canada] ; Barry J. Snow [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Age‐dependent decline of dopamine D1 receptors in human brain: A PET study
003A81 Francois J. G. Vingerhoets [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; Donald B. Snow [Canada, Nouvelle-Zélande]Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
003D25 Hitoshi Shinotoh [Canada] ; Francois J. G. Vingerhoets [Canada] ; Michael Schulzer [Canada] ; Barry J. Snow [Canada]The presymptomatic period in a patient with idiopathic parkinsonism
004281 Michael Cordes [Allemagne] ; Michael Snow [Canada] ; Sandra Cooper [Canada] ; Michael Schulzer [Canada] ; Brian D. Pate [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada]Age‐dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their grandchildren
004383 Michael Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]Reply
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022